Literature DB >> 8806028

Analysis of cognitive function in animals, the value of SDT.

H M Marston1.   

Abstract

The search for a better understanding of cognitive decline in man has lead to the use of increasingly complex procedures in animal research. The analysis of the data generated in such experiments has been greatly facilitated by the wider use of computer assisted techniques. These techniques can only be as good as the hypotheses they are used to test. Signal detection theory (SDT) provides a rational framework within which to work. The procedures are derived from human cognitive neuropsychology and are already used to some extent in primate but to a lesser degree in rodent research. The use of SDT offers two main advantages: first, a testable hypothesis as to the manner in which competing processes arrive at choice between various courses of action; second, the statistical procedures offer clear advantages over more traditional approaches by reducing the chances of misinterpretation. Though relatively easy to apply some care must be exercised in the protocol design and the choice of SDT indices if the full value of the approach is to be achieved. If experimental designs can be developed to include the appropriate use of SDT analysis; both the power of such protocols, and their value in the understanding of cognitive function, will provide a major step forward for animal-based research.

Entities:  

Mesh:

Year:  1996        PMID: 8806028     DOI: 10.1016/0926-6410(96)00012-2

Source DB:  PubMed          Journal:  Brain Res Cogn Brain Res        ISSN: 0926-6410


  11 in total

1.  Modeling games from the 20th century.

Authors:  P R. Killeen
Journal:  Behav Processes       Date:  2001-05-03       Impact factor: 1.777

2.  GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders.

Authors:  Jared W Young; Mary E Kamenski; Kerin K Higa; Gregory A Light; Mark A Geyer; Xianjin Zhou
Journal:  Neuropsychopharmacology       Date:  2015-04-24       Impact factor: 7.853

3.  Rats tested after a washout period from sub-chronic PCP administration exhibited impaired performance in the 5-Choice Continuous Performance Test (5C-CPT) when the attentional load was increased.

Authors:  Sam A Barnes; Jared W Young; Jo C Neill
Journal:  Neuropharmacology       Date:  2011-05-05       Impact factor: 5.250

4.  The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding.

Authors:  Jared W Young; Susan B Powell; Christine N Scott; Xianjin Zhou; Mark A Geyer
Journal:  Behav Brain Res       Date:  2011-03-31       Impact factor: 3.332

5.  D₁ receptor activation improves vigilance in rats as measured by the 5-choice continuous performance test.

Authors:  Samuel A Barnes; Jared W Young; Jo C Neill
Journal:  Psychopharmacology (Berl)       Date:  2011-09-08       Impact factor: 4.530

6.  Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test.

Authors:  Jared W Young; Jessica M Meves; Mark A Geyer
Journal:  Behav Brain Res       Date:  2012-11-29       Impact factor: 3.332

7.  Uncertainty in pigeons.

Authors:  Leslie M Sole; Sara J Shettleworth; Patrick J Bennett
Journal:  Psychon Bull Rev       Date:  2003-09

8.  Signal detection in animal psychoacoustics: analysis and simulation of sensory and decision-related influences.

Authors:  A Alves-Pinto; J Sollini; C J Sumner
Journal:  Neuroscience       Date:  2012-06-12       Impact factor: 3.590

9.  The 5-choice continuous performance test: evidence for a translational test of vigilance for mice.

Authors:  Jared W Young; Gregory A Light; Hugh M Marston; Richard Sharp; Mark A Geyer
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

10.  Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice.

Authors:  J W Young; M A Geyer; A J Rissling; R F Sharp; L T Eyler; G L Asgaard; G A Light
Journal:  Transl Psychiatry       Date:  2013-11-12       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.